StayCurrentMD · Congenital Pulmonary Airway Malformation: APSA Prenatal Counseling Series
Guideline2 min read·Published Sep 2020Older

Congenital Pulmonary Airway Malformation: APSA Prenatal Counseling Series

Guideline · Sep 2020 · 2 min read

In brief

In brief

Educational resource from APSA's Fetal Diagnosis and Treatment Committee providing prenatal counseling guidance for congenital pulmonary airway malformation (CPAM). Designed to help clinicians discuss diagnosis, prognosis, and management options with expectant families.

  • CVR <1.6 indicates low-risk CPAM; manage expectantly with serial ultrasounds every 4 weeks and weekly CVR monitoring.
  • CVR >1.6 carries 75% hydrops risk; refer to fetal center for betamethasone, frequent monitoring, and potential fetal intervention.
  • Macrocystic lesions with hydrops <32 weeks require thoracoamniotic shunt; microcystic lesions may need open fetal resection.
  • 50-60% of CPAMs regress prenatally; peak growth occurs at 26-28 weeks gestation before potential involution.
  • Postnatal risks include air trapping causing respiratory distress, recurrent infections, and rare malignant transformation to PPB.

Written by the GCMD Library team from the guideline.

Differential Diagnosis of Cystic Lung Lesions

Prenatally diagnosed cystic lung lesions include congenital pulmonary airway malformation (CPAM), bronchopulmonary sequestration (BPS), hybrid lesions, bronchial atresia, congenital diaphragmatic hernia, and bronchopulmonary foregut malformations. Accurate differentiation is essential for appropriate prenatal counseling and management planning.

CPAM Volume Ratio (CVR) Measurement

CVR is calculated by estimating CPAM volume using the prolate ellipse formula (length × height × width × 0.52) divided by head circumference. This standardized measurement is the primary prognostic tool for risk stratification and guides management decisions throughout pregnancy.

Initial Prenatal Evaluation

Comprehensive evaluation includes obstetrical ultrasound to characterize lesion morphology (microcystic vs macrocystic), measure CVR, assess for mediastinal shift and hydrops, and identify systemic feeding vessels. Fetal echocardiography evaluates cardiac structure, function, and vascular supply, while fetal MRI further delineates anatomy and vasculature when needed.

Prenatal Counseling and Management Strategy

Low-risk lesions (CVR < 1.6) are managed expectantly with serial ultrasounds every four weeks and weekly CVR monitoring. High-risk lesions (CVR > 1.6) require referral to a fetal center, weekly or twice-weekly ultrasounds, maternal betamethasone administration, and consideration of fetal intervention (thoracoamniotic shunt for macrocystic lesions with hydrops < 32 weeks, open fetal resection for microcystic lesions, or EXIT procedure for hydrops > 32 weeks).

Prenatal Natural History and Prognosis

CPAMs typically demonstrate progressive growth until 26-28 weeks gestation, with regression occurring in 50-60% of cases. CVR at initial presentation is the key prognostic indicator, with CVR > 1.6 carrying a 75% risk of hydrops. Complications include pulmonary hypoplasia from mass effect and polyhydramnios from esophageal obstruction.

Postnatal Considerations and Risks

Perinatal air trapping within cysts may cause respiratory distress requiring immediate intervention. Communication with airways predisposes to recurrent pulmonary infections. Malignant degeneration to pleuropulmonary blastoma (PPB) is a recognized long-term risk requiring surveillance.

Statements in this guideline

  1. Differential diagnosis of a prenatally diagnosed cystic lung lesion includes congenital pulmonary airway malformation (CPAM), bronchopulmonary sequestration (BPS), hybrid lesions, bronchial atresia, congenital diaphragmatic hernia and bronchopulmonary foregut malformations.

    EstablishedDifferential Diagnosis
  2. CPAM volume is estimated using the formula for prolate ellipse: CPAM volume = (length x height x width x 0.52).

    GuidelineHow to Measure CVR
  3. CPAM volume ratio = CPAM volume/head circumference.

    GuidelineHow to Measure CVR
  4. Document whether the lesion is microcystic (multiple cysts, solid <5mm) or macrocystic (>5mm).

    RecommendationInitial Evaluation
  5. Search for a systemic feeding vessel to identify BPS/hybrid lesion.

    RecommendationInitial Evaluation
  6. Measure the CPAM Volume Ratio (CVR).

    RecommendationInitial Evaluation
  7. For low-risk lesions (CVR < 1.6), perform weekly CVR and growth ultrasounds every four weeks.

    RecommendationPrenatal Counseling
  8. Expectant management is appropriate in low-risk cases without a dominant cyst.

    RecommendationPrenatal Counseling
  9. In the presence of a dominant cyst (> 2cm), consider an MRI at 34 weeks GA to evaluate for hyperinflation/mediastinal shift and need for delivery at a tertiary center with ECMO capability.

    RecommendationPrenatal Counseling
  10. High-risk lesions (CVR > 1.6) require referral to a fetal center.

    RecommendationPrenatal Counseling
  11. For high-risk lesions, perform weekly or twice weekly ultrasounds depending on severity.

    RecommendationPrenatal Counseling
  12. Administer betamethasone 12mg IM to be repeated in 24-48 hours for high-risk lesions.

    RecommendationPrenatal Counseling
  13. Consider fetal MRI at 34 weeks for high-risk lesions.

    RecommendationPrenatal Counseling
  14. For hydrops < 32 weeks GA with a macrocystic lesion, perform thoracoamniotic shunt.

    RecommendationPrenatal Counseling
  15. For hydrops < 32 weeks GA with a microcystic lesion, perform open fetal resection.

    RecommendationPrenatal Counseling
  16. For hydrops > 32 weeks GA, perform EXIT-to-fetal CPAM resection.

    RecommendationPrenatal Counseling
  17. For hydrops > 32 weeks GA, perform emergent Cesarean section with ECMO standby and postnatal resection.

    RecommendationPrenatal Counseling
  18. Prenatal natural history is characterized by progressive growth until 26-28 weeks GA.

    EstablishedPrenatal Considerations
  19. CPAM may regress in up to 50-60% of cases.

    ResearchPrenatal Considerations
  20. CVR at first presentation is prognostic, with CVR < 1.6 indicating good prognosis.

    EstablishedPrenatal Considerations
  21. Lesions with a CVR > 1.6 have a 75% risk of hydrops.

    ResearchPrenatal Considerations
  22. Pulmonary hypoplasia may occur secondary to mass effect.

    EstablishedPrenatal Considerations
  23. Polyhydramnios may occur secondary to esophageal obstruction.

    EstablishedPrenatal Considerations
  24. Perinatal air trapping within the cysts may occur, resulting in respiratory distress.

    EstablishedPostnatal Considerations
  25. Communication with the airways may result in recurrent infections.

    EstablishedPostnatal Considerations
  26. Malignant degeneration to pleuro-pulmonary blastoma (PPB) is reported.

    ResearchPostnatal Considerations
Full text

American Pediatric Surgical Association Prenatal Counseling Series Congenital Pulmonary Airway Malformation from the Fetal Diagnosis and Treatment Committee of the American Pediatric Surgical Association Editor-in-Chief: Ahmed I. Marwan, MD ©2018, American Pediatric Surgical Association TM

American Pediatric Surgical Association Prenatal Counseling Series Congenital Pulmonary Airway Malformation Differential Diagnosis Differential diagnosis of a prenatally diagnosed cystic lung lesion includes: congenital pulmonary airway malformation (CPAM), bronchopulmonary sequestration (BPS), hybrid lesions, bronchial atresia, congenital diaphragmatic hernia and bronchopulmonary foregut malformations. Courtesy of Mariana Meyers, MD, Colorado Fetal Care Center

American Pediatric Surgical Association Prenatal Counseling Series Congenital Pulmonary Airway Malformation How to Measure CVR The CPAM volume is estimated using the formula for prolate ellipse CPAM volume = (length x height x width x 0.52) CPAM volume ratio = CPAM volume/head circumference

American Pediatric Surgical Association Prenatal Counseling Series Congenital Pulmonary Airway Malformation Initial Evaluation Obstetrical Ultrasound Fetal echocardiography Fetal magnetic resonance imaging Obstetrical Ultrasound • For anatomy, growth and fluid • Document whether the lesion is microcystic (multiple cysts, solid <5mm) or macrocystic (>5mm) • Search for a systemic feeding vessel: BPS/hybrid lesion • Measure the CPAM Volume Ratio (CVR) • Mediastinal shift • Signs of hydrops: pleural fluid, ascites, pericardial fluid, skin edema, placentamegaly Echo • Cardiac structure and function • Vascular supply of the lesion • Pulmonary veins • Signs of hydrops Fetal MRI • Delineate anatomy • Vascular supply

American Pediatric Surgical Association Prenatal Counseling Series Congenital Pulmonary Airway Malformation Prenatal Counseling Low-risk lesions (CVR < 1.6) • Weekly CVR and growth Ultrasounds every four weeks • Expectant management in low-risk cases without a dominant cyst • In the presence of a dominant cyst (> 2cm), consider an MRI at 34 weeks GA to evaluate for hyperinflation/mediastinal shift and need for delivery at a tertiary center with ECMO capability High-risk lesions (CVR > 1.6) Referral to a fetal center • Weekly or twice weekly ultrasounds depending on severity • Betamethasone 12mg IM to be repeated in 24-48 hours • Consider fetal MRI at 34 weeks • Hydrops < 32 weeks GA o Macrocystic lesion: thoracoamniotic shunt o Microcystic lesion: open fetal resection • Hydrops > 32 weeks GA o EXIT-to-fetal CPAM resection • Emergent Cesarean section with ECMO standby and postnatal resection

American Pediatric Surgical Association Prenatal Counseling Series Congenital Pulmonary Airway Malformation Prenatal Considerations • Usually diagnosed on a prenatal screening ultrasound • Prenatal natural history characterized by progressive growth until 26-28 weeks GA • May regress in up to 50-60% of cases • CVR at first presentation is prognostic. CVR < 1.6 = good prognosis. • Pulmonary hypoplasia may occur secondary to mass effect • Polyhydramnios may occur secondary to esophageal obstruction • Lesions with a CVR > 1.6 have a 75% risk of hydrops Postnatal Considerations • Perinatal air trapping within the cysts may occur, resulting in respiratory distress • Communication with the airways may result in recurrent infections • Malignant degeneration to pleuro-pulmonary blastoma (PPB) is reported

Open in a new tab ↗

Read it at the source ↗

Try
Intelligent Search· scoped to this guideline · not medical adviceSearch the whole library →